Filing Details
- Accession Number:
- 0001209191-21-024238
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-01 18:23:16
- Reporting Period:
- 2021-03-30
- Accepted Time:
- 2021-04-01 18:23:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1807120 | Design Therapeutics Inc. | DSGN | Pharmaceutical Preparations (2834) | 823929248 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848319 | Sr One Capital Fund I Aggregator Lp | 985 Old Eagle School Road, Suite 511 Wayne PA 19087 | No | No | Yes | No | |
| 1853723 | Sr One Capital Management, Llc | 985 Old Eagle School Road, Suite 511 Wayne PA 19087 | No | No | Yes | No | |
| 1853724 | Sr One Capital Partners I, Lp | 985 Old Eagle School Road, Suite 511 Wayne PA 19087 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-30 | 4,439,839 | $0.00 | 4,439,839 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-03-30 | 936,637 | $0.00 | 5,376,476 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-03-30 | 250,000 | $20.00 | 5,626,476 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2021-03-30 | 7,236,938 | $0.00 | 4,439,839 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2021-03-30 | 1,526,718 | $0.00 | 936,637 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A Preferred Stock and the Series B Preferred Stock were converted into Common Stock on a 1.63-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock and Series B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- SR One Capital Fund I Aggregator, LP purchased 250,000 shares of Common Stock of Design Therapeutics, Inc. (the "Issuer") in connection with the Issuer's public offering.
Billionaire Hedge Funds
